Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page header/footer shows an update to the interface version from v3.5.2 to v3.5.3, indicating a software/display release rather than a change to the trial record itself.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the history page.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed from the page history.SummaryDifference0.1%

- Check100 days agoChange DetectedThe footer revision label has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.